Risk of dementia in diabetes mellitus: a systematic review.

By Geert Jan Biessels, Salka S. Staekenborg, E. Brunner, Carol Brayne, Philip Scheltens. Lancet Neurology, 2006

2,120 citations recorded by the source corpus.

Subfields: Neurology, Physiology, Psychiatry and Mental health

View Paper: https://www.semanticscholar.org/paper/e31a373bc94c4485f348ff98d71acb0db0ade3fc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

1. Julie A. Schneider
2. David A. Bennett
3. R. Wilson
4. John Q. Trojanowski
5. C. Zhong
6. V. Basevi
7. Zhichun Chen
8. C. Iadecola

In Physiology

1. Julie A. Schneider
2. David A. Bennett
3. R. Wilson
4. B. K. Pedersen
5. Zoe Arvanitakis
6. A. M. Petersen
7. C. Fischer
8. A. Nielsen

In Psychiatry and Mental health

1. David A. Bennett
2. Julie A. Schneider
3. Zoe Arvanitakis
4. R. Wilson
5. John Q. Trojanowski
6. B. K. Pedersen
7. C. Zhong
8. V. Basevi

Citations in the corpus

• Standards of Medical Care in Diabetes—2013 (2012, background): “Cognitive impairment Diabetes is associated with significantly increased risk of cognitive decline, a greater rate of cognitive decline, and increased risk of dementia (408,409).”
• Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. (2013, background): “The related observations have been documented by a huge amount of clinical and experimental studies (Biessels et al., 2006; Craft, 2005; Euser et al., 2010; Münch et al., 1998).”
• Standards of Medical Care in Diabetes—2012 (2011, background): “Cognitive impairment Diabetes is associated with significantly increased risk of cognitive decline, a greater rate of cognitive decline, and increased risk of dementia (361,362).”
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. (2012, positive): “Such a large set of shared features suggests shared etiologies, a view supported by epidemiologic studies showing that AD risk is increased 50%–100% by diabetes (5–8), including T2D (9), which accounts for 90% of all diabetic cases (10).”
• Brain-derived neurotrophic factor (BDNF) and type 2 diabetes (2007, background): “A recent review [15] showed that the incidence of ‘any dementia’ was higher in individuals with type 2 diabetes than in those without.”
• Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective (2015, neutral): “[21] Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P.”
• Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies (2013, background): “Seven out of 10 studies by Biessels et al.47 and five out of nine studies by Kloppenborg et al.53 reported a higher risk of dementia in patients with diabetes.”
• Inflammation as a central mechanism in Alzheimer's disease (2018, background): “[246] Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P.”